Skip to content

Medical-device intelligence

QMI: Nucleic Acid Amplification Test For The Quantitation Of Bk Virus (Bk) Dna

FDA product code QMI: Nucleic Acid Amplification Test For The Quantitation Of Bk Virus (Bk) Dna. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
QMI
FDA device name
Nucleic Acid Amplification Test For The Quantitation Of Bk Virus (Bk) Dna
Device class
2
Regulation number
866.3183
Medical specialty
Microbiology
Review panel
MI

FDA definition

An in vitro nucleic acid amplification test for the quantitation of BK virus (BKV) DNA in human samples intended for use as an aid in the management of BKV in transplant patients. In patients undergoing monitoring of BKV, serial DNA measurements can be used to indicate the need for potential treatment changes and to assess viral response to treatment. Test results are intended to be read and analyzed by a qualified licensed healthcare professional in conjunction with clinical signs and symptoms and relevant laboratory findings. Test results must not be the sole basis for patient management decisions.
Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

2 clearance records and 0 recall records in the covered releases, across 2 source company names and 1 product codes. Dated history runs from Sep 2, 2020 to Mar 24, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

2 matching records
Device / recordCompany in FDA recordSourceSource date
Alinity m BKVK241921 · QMIAbbott Molecular, Inc.510(k)Mar 24, 2025FDA decision date
cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control KitK202215 · QMIRoche Molecular Systems, Inc.510(k)Sep 2, 2020FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗